Smitsomme sygdomme. Infektioner

"By presenting chapter-specific roadmaps, this book offers a behind-the-scenes chronology of the response to COVID-19 and provides a rubric for future pandemic response. Targeted at lay and scientific audiences, reflections and lessons learned grant the reader an opportunity to leverage this knowledge and improve the outcomes of future pandemics"--

I vaccini mRNA COVID-19 stanno inducendo un'immunosoppressione temporanea di breve durata che consente al citomegalovirus (CMV) di riattivarsi in alcune persone. Questa riattivazione del citomegalovirus può causare miocardite e sindrome di Guillain-Barré e una miriade di altri disturbi. Il citomegalovirus è altamente ubiquitario in natura e comune nelle persone di tutte le età e fa parte di una famiglia di herpesvirus che causano la varicella e la mononucleosi negli adolescenti. Dopo l'infezione, il CMV rimane dormiente nel corpo della maggior parte degli esseri umani per tutta la vita, ma può riattivarsi durante la soppressione immunitaria. Una ridotta suscettibilità al CMV negli uomini di età superiore ai 45 anni potrebbe essere la ragione per cui si verificano rari casi di miocardite nei giovani che hanno assunto il vaccino a mRNA. La suscettibilità al CMV aumenta tra i 16 ei 45 anni. Trattamenti, farmaci e persino vaccini possono sopprimere temporaneamente il sistema immunitario e causare la riattivazione del CMV. Questo dovrebbe essere considerato come una possibile causa di casi di miocardite e Guillain-Barré in coloro che hanno assunto il vaccino mRNA COVID-19.

MicroRNA in Human Infectious Diseases offers an overview of the therapeutic and diagnostic role microRNAs can play in treating infectious diseases. Beginning with an introduction on microRNAs and their mechanisms, the book then delves into the therapeutic role of microRNAs in various categories of diseases, including bacterial, viral, and parasitic. A wide range of diseases are explored, including STDs, typhoid, tuberculosis, Dengue fever, Ebola, Covid-19, Malaria, Leishmaniasis, and Lymphatic filariasis. The final section of the book covers microRNA-based system approaches, considering aspects such as web-based tools available for detecting and predicting microRNA targets and the latest technologies for modifying and manipulating microRNAs. This volume explores microRNA across a multitude of conditions and is an ideal reference for those involved in the investigation and development of treatments in this area.

Drawing on international perspectives and research, this book explores the experiences of sex and sexuality in individuals and groups living with HIV in later life (50+).

Szczepionki mRNA COVID-19 mog¿ wywo¿ywä krótkotrwä¿ tymczasow¿ immunosupresj¿, umo¿liwiaj¿c reaktywacj¿ wirusa cytomegalii (CMV) u niektórych osób w bardzo rzadkich przypadkach. Ta reaktywacja wirusa cytomegalii mo¿e w rzadkich przypadkach powodowä zapalenie mi¿¿nia sercowego i zespó¿ Guillain-Barré oraz wiele innych dolegliwo¿ci. Wirus cytomegalii jest wysoce wszechobecny w przyrodzie i powszechny u osób w kädym wieku i nale¿y do rodziny wirusów opryszczki, które powoduj¿ osp¿ wietrzn¿ i mononukleoz¿ u nastolatków. Po zakäeniu CMV pozostaje u¿piony w organizmie wi¿kszo¿ci ludzi przez cäe ¿ycie, ale mo¿e zostä reaktywowany podczas supresji immunologicznej. Zmniejszaj¿ca si¿ podatno¿¿ na CMV u m¿¿czyzn w wieku powy¿ej 45 lat mo¿e by¿ przyczyn¿ rzadkich przypadków zapalenia mi¿¿nia sercowego u m¿odszych osób, które przyj¿¿y szczepionk¿ mRNA. Podatno¿¿ na CMV wzrasta w wieku od 16 do 45 lat. Leczenie, leki, a nawet szczepionki mog¿ tymczasowo t¿umi¿ uk¿ad odporno¿ciowy i powodowä reaktywacj¿ CMV. Jest to jednak bardzo rzadkie, ale nale¿y je rozwäy¿ jako mo¿liw¿ przyczyn¿ rzadkich przypadków zapalenia mi¿¿nia sercowego i Guillain-Barré u osób, które przyj¿¿y szczepionk¿ mRNA COVID-19.

This book offers a comprehensive overview of recent trends in viral outbreaks, covering general concepts of immunobiology of infections, viral outbreaks, pathology, virology, viral genomics, viromes, and antiviral pharmacology. It also discusses current clinical recommendations for managing various viral diseases, highlighting ongoing issues, recent advances, and future directions in diagnostic approaches and therapeutic strategies. The book focuses on various aspects and properties of viral outbreaks, whose in-depth understanding is crucial to protect humanity from further losses of resources and economies due to viral diseases. It provides an overview of recent developments in the detection, monitoring, treatment, and control of several viral diseases that have caused recent epidemics or pandemics.

Bacterial sexually transmitted infections (STIs) are among the most widespread infections worldwide, causing major health problems. Bacterial Sexually Transmitted Infections - New Findings, Diagnosis, Treatment, and Prevention is a collection of chapters written by experts in the field from all over the globe. It includes recent scientific knowledge and advances in various approaches to the diagnosis, control, treatment, and management of bacterial STIs, depending on available resources and facilities. It presents research from the literature as well as different viewpoints to open new perspectives in this field. It is designed to improve the knowledge of those interested in bacterial STIs and new methods for their diagnosis and treatment.

Malaria remains a leading cause of morbidity and mortality worldwide. Children in Africa and selected regions of Asia and Southern America are especially widely affected. Written by expert research teams, this book describes different aspects of the epidemiology, pathobiology, diagnosis, prevention, and treatment of malaria. Chapters highlight current research as well as the gold standards for diagnosis and treatment of the disease, examining recent advances, remaining pitfalls, and novel ideas about prophylaxis and therapy.

Nanostructured Drug Delivery Systems in Infectious Disease Treatment explores a broad range of promising approaches for the treatment of infectious diseases using the latest advancements in nanomedical technologies. The book opens with an introduction about infectious diseases and global burdens. There is also specific discussion and assessment of the global impact of viruses with an emphasis on COVID-19, Zika, and Ebola. Subsequent chapters provide detailed information about various novel nanotherapeutic strategies used for delivering drugs for the treatment of various types of viral, bacterial, and fungal disorders. This will be a valuable resource for graduates, researchers, industry professionals, and anyone working to tackle the challenges of delivering drugs in a more targeted and efficient manner for the treatment of infectious diseases.

A prize-winning New York Times reporter reflects on 25 years of covering pandemics—how governments react to them, how the media covers them, how they are exploited, and what we can do to prepare for the next one.

From the difficult to diagnose to the difficult to treat, this book prepares you to handle whatever your patients may have contracted. Featuring an internationally recognized editorial team, global contributors, and expert authors, it provides you with the advanced coverage on parasitic and infectious diseases from around the world.

The U.S. military has a long history of vaccinating service members against infectious disease as a military necessity to protect soldiers and contribute to the overall mission readiness of the force. The coronavirus disease 2019 (COVID-19) pandemic has once again demonstrated the importance of the health and readiness of the force. In this report, the authors examine how the Department of Defense (DoD) COVID-19 vaccination program was developed and implemented, determine how previous DoD vaccination programs influenced those decisions, and identify opportunities to strengthen the department's vaccination program, particularly against emerging infectious diseases, such as COVID-19. They examine the laws and policies that guide the overall DoD vaccination program, study lessons learned from other DoD vaccination programs, and determine the policies for handling medical and administrative (including religious) exemptions. The authors also created an exploratory framework for considering vaccine acceptability-including the key attributes of a vaccination campaign-which could provide an important basis for thinking about how to manage future DoD vaccination campaigns.

The Minor Horrors of War by Sir A. E. Shipley has been regarded as significant work throughout human history, and in order to ensure that this work is never lost, we have taken steps to ensure its preservation by republishing this book in a contemporary format for both current and future generations. This entire book has been retyped, redesigned, and reformatted. Since these books are not made from scanned copies, the text is readable and clear.

In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship  has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field. Contains 12 practice-oriented topics including antimicrobial stewardship and pandemic preparedness: lessons learned from COVID-19; health equity considerations; antimicrobial stewardship at transitions of care; antimicrobial stewardship in immunocompromised populations; health system and tele-antimicrobial stewardship: the role of building networks; and more.  Provides in-depth clinical reviews on antimicrobial stewardship, offering actionable insights for clinical practice.  Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This apolitical book is a gem of investment dedicated to humankind worldwide - YES, Including you. It ethically and beneficially clears the evil cobwebs of sinful deceit woven by Occidental Media Barons, BIG PHARMA, and Military Industrial Complexes. It also diverts taxpayers' monies into their pockets!Their greed is boundless.

Advances in Virus Research, Volume 117, the latest release in a series that highlights new advances in the field, includes invaluable updates written by an international board of authors. Chapters in this new release include Pathogenesis of neuroinvasive flaviviruses, Cellular entry and egress of astroviruses, Rift Valley Fever virus entry and infection, and more.

In this issue of MRI Clinics, guest editors Prof. Minerva Becker and Dr. Valentino Garibotto bring their considerable expertise to the topic of Clinical Value of Hybrid PET/MRI. Combined PET/MRI has significant advantages over other imaging methods-a lesser radiation dose, excellent soft tissue contrast, numerous radiotracers available for PET, and more, making it a good choice for diagnostics and staging, as well as surgical planning. In this issue, top experts explore these advantages and more, helping you make the most of this relatively new dual-imaging modality in your practice. Contains 10 relevant, practice-oriented topics including breast imaging using PET/MRI; abdominal imaging using PET/MRI; brain imaging using PET/MRI; musculoskeletal imaging using PET/MRI; PET/MRI in radiation therapy planning; pediatric imaging using PET/MRI; and more. Provides in-depth clinical reviews on the clinical value of hybrid PET/MRI, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Dominik Mattes examines the implementation of antiretroviral HIV-treatment (ART) in Tanzania, exploring the manifold infrastructural and social fragilities of treatment provision in public HIV clinics as well as patients' multi-layered struggles of coming to terms with ART in their everyday lives.

Dengue Fever in a One Health Perspective - Latest Research and Recent Advances presents studies on dengue fever (DF) and dengue virus (DENV) that discuss eco-epidemiology, physiopathology, and new biotechnological tools to fight against this important disease in the context of the World Health Organization¿s One Health strategy. The book is organized into five sections: ¿Epidemiological Aspects¿, ¿Environmental Aspects¿, ¿Pathogenicity¿, ¿Diagnosis and Treatment¿ and ¿Management Strategies¿. The chapters address topics such as DF prevalence and management in a Chinese county, the risk of DF in American children younger than 15 years, the silent transmission of DENV by asymptomatic individuals, the use of X-ray and ultrasound to identify severe DF cases, gene-silencing techniques to investigate biological aspects of DF, viral genomic surveillance to promote early intervention in DF epidemics, and much more.

The study of staphylococci has a long way to go, due to the great significance both for humans and for dairy or companion animals of their large number of virulence factors. Their resistance to antibiotics makes these microorganisms become highly pathogenic species that can cause infections ranging from mild to fatal. Staphylococci, especially S. aureus and strains resistant to methicillin (MRSA), are among the most studied microorganisms worldwide. This book covers recent advances in the study of staphylococci. The book is divided into four sections that cover four important events for the study and combat of staphylococci: colonization, epidemiology and pathogenesis, diagnosis, and new treatments. Staphylococci can present a broad spectrum of resistance to antibiotics, which is why their elimination has become difficult. The final section of the book is devoted to new compounds for the fight against staphylococci. We hope that the information contained in this book will be useful for the study and investigation of these medically important microorganisms.